FdaApplication
ANDA 204515
Identifiers
- fda_app_no: ANDA204515
Properties
| Property | Value |
|---|---|
| applicant_name | NCM USA BRONX LLC |
| application_type | ANDA |
| approval_date | 2015-02-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMMONIA N 13 | AMMONIA N-13 | 3.75mCi-260mCi/ML | INJECTABLE;INTRAVENOUS |
1 product